Kentucky 2024 Regular Session

Kentucky Senate Bill SB1

Introduced
2/8/24  
Refer
2/8/24  
Refer
2/12/24  
Report Pass
2/22/24  
Engrossed
2/29/24  
Refer
2/29/24  
Refer
3/6/24  
Report Pass
3/25/24  
Enrolled
3/27/24  
Enrolled
3/27/24  

Caption

AN ACT relating to the endowed research fund and making an appropriation therefor.

Impact

The introduction of the endowed research fund is anticipated to promote collaboration between public universities and foster innovation within the state. By funding high-quality research consortiums, SB1 aims to improve Kentucky's overall research capabilities and stimulate advancements in various fields, particularly healthcare and economic development. The allocation of funds will be reviewed periodically, ensuring that only the most effective consortiums are supported over time. This initiative represents a strategic investment in higher education and research infrastructure in Kentucky.

Summary

SB1 proposes the establishment of an endowed research fund in Kentucky aimed at supporting research initiatives by public universities. The fund, created under KRS Chapter 164, will be administered by a designated council and will encompass several consortium accounts. These accounts will pool resources from the state general fund, federal funds, and other contributions to provide financial backing for research consortiums selected by the council. Each consortium is expected to utilize these funds as seed money to enable initial research efforts and further seek additional funding from external sources.

Sentiment

Overall sentiment surrounding SB1 appears positive, especially among proponents who view it as a chance to enhance Kentucky's position in the realm of research and innovation. Supporters argue that the establishment of the fund will not only bolster academic research but also contribute to the state’s workforce development and attract new businesses driven by technological advancements. However, there may also be some concerns regarding funding limitations and the long-term sustainability of the program, particularly how the effectiveness of the chosen consortiums will be assessed.

Contention

While the bill is largely well-received, debates may arise over the selection criteria and performance metrics for the consortiums receiving funding. Some stakeholders could argue for greater accountability and transparency in how funds are awarded and utilized. Additionally, there might be differing views on the focus of research areas prioritized by the council, potentially leading to discussions on how best to balance interests across various sectors of the economy and community needs within Kentucky.

Companion Bills

No companion bills found.

Similar Bills

TX SB264

Relating to the establishment of the Texas Research Consortium to Cure Infectious Diseases (TRANSCEND); authorizing the issuance of bonds.

FL S1800

Parkinson's Disease

FL H1545

Parkinson's Disease

TX SB73

Relating to the establishment of an adult stem cell research program and to certain reporting requirements with regard to research involving human stem cells or human cloning.

TX HB2379

Relating to the establishment of an adult stem cell research program.

TX SR693

Suspending limitations on conference committee jurisdiction on H.B. 3447.

TX HR2432

Suspending limitations on conference committee jurisdiction, H.B. No. 3447.

TX HB2342

Relating to the research, collection, and use of adult stem cells.